BioLife Solutions (NASDAQ:BLFS – Get Free Report) and Vivani Medical (NASDAQ:VANI – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations.
Analyst Ratings
This is a summary of current recommendations and price targets for BioLife Solutions and Vivani Medical, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| BioLife Solutions | 0 | 0 | 7 | 0 | 3.00 |
| Vivani Medical | 0 | 0 | 1 | 0 | 3.00 |
BioLife Solutions currently has a consensus target price of $29.43, suggesting a potential upside of 3.91%. Vivani Medical has a consensus target price of $3.00, suggesting a potential upside of 158.62%. Given Vivani Medical’s higher possible upside, analysts plainly believe Vivani Medical is more favorable than BioLife Solutions.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| BioLife Solutions | $146.96 million | 8.94 | -$66.43 million | ($1.06) | -26.72 |
| Vivani Medical | N/A | N/A | -$25.65 million | ($0.45) | -2.58 |
Vivani Medical has lower revenue, but higher earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares BioLife Solutions and Vivani Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| BioLife Solutions | -38.98% | -6.61% | -5.54% |
| Vivani Medical | N/A | -102.42% | -49.21% |
Volatility & Risk
BioLife Solutions has a beta of 1.91, indicating that its stock price is 91% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 3.22, indicating that its stock price is 222% more volatile than the S&P 500.
Institutional & Insider Ownership
93.2% of BioLife Solutions shares are held by institutional investors. Comparatively, 6.8% of Vivani Medical shares are held by institutional investors. 2.2% of BioLife Solutions shares are held by company insiders. Comparatively, 44.3% of Vivani Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
Vivani Medical beats BioLife Solutions on 7 of the 12 factors compared between the two stocks.
About BioLife Solutions
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
About Vivani Medical
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
